RO84079B1 - Compozitie medicamentoasa pentru tratamentul topic al mastopatiilor benige - Google Patents

Compozitie medicamentoasa pentru tratamentul topic al mastopatiilor benige

Info

Publication number
RO84079B1
RO84079B1 RO111623A RO11162383A RO84079B1 RO 84079 B1 RO84079 B1 RO 84079B1 RO 111623 A RO111623 A RO 111623A RO 11162383 A RO11162383 A RO 11162383A RO 84079 B1 RO84079 B1 RO 84079B1
Authority
RO
Romania
Prior art keywords
benign
progesterone
medicinal composition
phenylbutazone
topic treatment
Prior art date
Application number
RO111623A
Other languages
English (en)
Other versions
RO84079A2 (ro
Inventor
Georgeta Calin
Alexandru Perju
Raisa Motocescu
ELISABETA GRîU
Constantin Filipovici
Original Assignee
Institutul Pentru Controlul De Stat Al Medicamentului Si Cercetari Farmaceutice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul Pentru Controlul De Stat Al Medicamentului Si Cercetari Farmaceutice filed Critical Institutul Pentru Controlul De Stat Al Medicamentului Si Cercetari Farmaceutice
Priority to RO111623A priority Critical patent/RO84079B1/ro
Publication of RO84079A2 publication Critical patent/RO84079A2/ro
Publication of RO84079B1 publication Critical patent/RO84079B1/ro

Links

Landscapes

  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Preparatul topic indicat în mastopatii benigne, pe baza de progesteron si fenilbutazona, reprezinta un medicament cu indicatii în patologia mamara benigna si profilactic, în prevenirea modificarilor vasculare si tisulare provocate de un deficit local de progesteron la nivelul sînilor. Compozitia medicamentoasa este constituita din: 1...1,5% progesteron, 4...5% fenilbutazona, 20...30% propilenglicol, 5...10% alcool cetilic, 0,5...1% laurilsulfat de sodiu, 5...10% parafina lichida, 0,01...0,025% p-hidroxibenzoat de propil, 8...10% vaselina, 0,5...0,7% parfum si apa distilata pîna la 100.
RO111623A 1983-07-14 1983-07-14 Compozitie medicamentoasa pentru tratamentul topic al mastopatiilor benige RO84079B1 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO111623A RO84079B1 (ro) 1983-07-14 1983-07-14 Compozitie medicamentoasa pentru tratamentul topic al mastopatiilor benige

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO111623A RO84079B1 (ro) 1983-07-14 1983-07-14 Compozitie medicamentoasa pentru tratamentul topic al mastopatiilor benige

Publications (2)

Publication Number Publication Date
RO84079A2 RO84079A2 (ro) 1984-05-12
RO84079B1 true RO84079B1 (ro) 1984-06-30

Family

ID=20113407

Family Applications (1)

Application Number Title Priority Date Filing Date
RO111623A RO84079B1 (ro) 1983-07-14 1983-07-14 Compozitie medicamentoasa pentru tratamentul topic al mastopatiilor benige

Country Status (1)

Country Link
RO (1) RO84079B1 (ro)

Also Published As

Publication number Publication date
RO84079A2 (ro) 1984-05-12

Similar Documents

Publication Publication Date Title
FR2558373B1 (fr) Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
GB1388836A (en) Cosmetic compositions
GB1471894A (en) Compositions for application to or consumption by the body and containing a compound having a physiological cooling effect
KR890700349A (ko) 피임 및 유방암 억제용 조성물 및 이의 제조방법
AU7023987A (en) Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE8402551L (sv) Cinnamoylmoranolin-derivat
DE69021214D1 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
JPH02115115A (ja) 入浴剤組成物
EP0265702A3 (en) A transparent or semitransparent jelly-like cosmetic composition
EP1005320A1 (en) Non-irritating composition for treating acne and other skin conditions
ES482723A1 (es) Un procedimiento para la obtencion de una composicion de clotrimazol
SE8301654D0 (sv) Dental cream composition
US3395236A (en) Composition comprising oleic acid, polyethylene glycol, and gelating for treating nail infections
RO84079B1 (ro) Compozitie medicamentoasa pentru tratamentul topic al mastopatiilor benige
ES2053055T3 (es) Proceso para la preparacion de un medicamento endermico con una base de gel.
BE763579A (fr) Nouvel ether de lysolecithine et utilisation des ethers de lysolecithines comme agents pour l'accroissement de la resistance naturelle de l'organisme
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
TW328049B (en) Penciclover/propylene glycol composition
EA199800218A1 (ru) Фармацевтический препарат с трипанозидными свойствами
El‐Hefnawi et al. Studies on Pityriasis Versicolor in Egypt: II. Clinical and Therapeutic
KR960033315A (ko) 홍화(紅花)를 주재로한 건강음료의 제조방법
Noguchi ABNORMAL BACTERIAL FLAGELLA
FR2073271A1 (en) Calcium salt - vitamin d2 compn - for treatment of decalcification of
BE781697A (fr) Procede et dispositif pour l'administration au corps humain de produitsliquides, visqueux ou gras, sous une forme ionisee
Purdy et al. Case report: epidermolysis bullosa acquisita